Bidford Healthcare Ltd

trading as Crabtree Pharmacy

(Registration number: 08237070)
Balance Sheet as at 31 March 2026

	Note	2026 £	2025 £
Fixed assets
Tangible assets	4	264,517	270,306
Current assets
Stocks	5	65,217	48,091
Debtors	6	90,799	80,421
Cash at bank and in hand		82,009	43,836
		238,025	172,348
Creditors: Amounts falling due within one year	7	(416,548)	(422,001)
Net current liabilities		(178,523)	(249,653)
Total assets less current liabilities		85,994	20,653
Creditors: Amounts falling due after more than one year	7	(143,756)	(152,143)
Net liabilities		(57,762)	(131,490)
Capital and reserves
Called up share capital		270	270
Revaluation reserve		26,321	26,736
Retained earnings		(84,353)	(158,496)
Shareholders' deficit		(57,762)	(131,490)

For the financial year ending 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 June 2026 and signed on its behalf by:
 

......................................... Dr T Shackley Director

......................................... Mr J Moll Director

......................................... Dr J Moloughney Director

Bidford Healthcare Ltd

trading as Crabtree Pharmacy

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

1	General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Crabtree Pharmacy
Stratford Road
Bidford-on-Avon
Alcester
B50 4LX

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis due to the continued support of the directors for a period of at least 12 months from the signing of the balance sheet.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Bidford Healthcare Ltd

trading as Crabtree Pharmacy

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Fixtures and fittings	25% reducing balance basis
Computer equipment	33% reducing balance basis
Freehold property	2% straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Bidford Healthcare Ltd

trading as Crabtree Pharmacy

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 10 (2025 - 7).

Bidford Healthcare Ltd

trading as Crabtree Pharmacy

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

4	Tangible assets

	Land and buildings £	Fixtures & fittings  £	Computer equipment  £	Total £
Cost or valuation
At 1 April 2025	300,000	15,064	1,915	316,979
At 31 March 2026	300,000	15,064	1,915	316,979
Depreciation
At 1 April 2025	31,625	13,556	1,492	46,673
Charge for the year	5,271	377	141	5,789
At 31 March 2026	36,896	13,933	1,633	52,462
Carrying amount
At 31 March 2026	263,104	1,131	282	264,517
At 31 March 2025	268,375	1,508	423	270,306

Included within the net book value of land and buildings above is £263,104 (2025 - £268,375) in respect of freehold land and buildings.
 

5

Stocks

	2026 £	2025 £
Other inventories	65,217	48,091

6

Debtors

Current	2026 £	2025 £
Trade debtors	79,455	70,742
Prepayments	2,082	2,115
Other debtors	9,262	7,564
	90,799	80,421

Bidford Healthcare Ltd

trading as Crabtree Pharmacy

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2026

7

Creditors

Creditors: amounts falling due within one year

	Note	2026 £	2025 £
Due within one year
Bank loans and overdrafts	8	8,387	7,890
Trade creditors		70,505	86,929
Amounts owed to related parties		316,209	316,209
Other creditors		21,447	10,973
		416,548	422,001

Creditors: amounts falling due after more than one year

	Note	2026 £	2025 £
Due after one year
Loans and borrowings	8	143,756	152,143

8	Loans and borrowings

Non-current loans and borrowings

	2026 £	2025 £
Bank borrowings	143,756	152,143

Current loans and borrowings

	2026 £	2025 £
Bank borrowings	8,387	7,890

9	Financial commitments, guarantees and contingencies

Amounts disclosed in the balance sheet

Included in the balance sheet are guarantees of £152,143 (2025 - £160,033). A fixed and floating charge dated 29 April 2022 is held by Lloyds Bank PLC covering all of the property or undertaking of the company.